Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients

NCT02271295 · clinicaltrials.gov ↗
PHASE3
Phase
SUSPENDED
Status
16
Enrollment
OTHER
Sponsor class

Stopped Premature discontinuation of inclusions by the sponsor for low inclusion

Conditions

Interventions

Sponsor

Assistance Publique - Hôpitaux de Paris